Seres Plans Deep Dive After Microbiome Drug Fails In Ulcerative Colitis Trial

 
• By Alaric DeArment
Bacterias 3D rendering
Seres will do a deep dive into data from its failed Phase IIb study of SER-287 in ulcerative colitis • Source: Shutterstock

More from Clinical Trials

More from R&D